Osteonecrosis due to drugs, tibia and fibula
ICD-10 M87.16 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs, tibia and fibula.
Osteonecrosis, also known as avascular necrosis, is a condition characterized by the death of bone tissue due to a lack of blood supply. In the case of M87.16, this condition specifically affects the tibia and fibula and is induced by the use of certain medications. Commonly implicated drugs include corticosteroids and bisphosphonates, which can disrupt the normal blood flow to the bones. Patients may present with symptoms such as pain, swelling, and limited range of motion in the affected limb. Diagnosis typically involves imaging studies such as MRI or X-rays, which can reveal changes in bone density and structure. If left untreated, osteonecrosis can lead to severe complications, including bone collapse and the need for surgical interventions such as joint replacement. The management of this condition often requires a multidisciplinary approach, including orthopedic specialists, pain management, and physical therapy.
Detailed history of medication use, imaging studies, and clinical findings.
Patients presenting with joint pain and a history of corticosteroid use.
Ensure that all imaging results are included in the documentation to support the diagnosis.
Comprehensive medication history, including duration and dosage of drugs that may contribute to osteonecrosis.
Patients with autoimmune disorders on long-term corticosteroid therapy.
Document any underlying conditions that may predispose the patient to osteonecrosis.
Used for pain management in patients with osteonecrosis.
Document the joint involved and the reason for the procedure.
Orthopedic specialists should ensure that the procedure is justified based on clinical findings.
Corticosteroids and bisphosphonates are the most commonly associated medications with osteonecrosis, particularly in long-term use.
